Treatment of Active Crohn’s Disease with Exclusive and Partial Enteral Nutrition: A Pilot Study in Adults | Zendy

Catherine L. Wall | Zendy; Richard B. Gearry | Zendy; Andrew S. Day | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Treatment of Active Crohn’s Disease with Exclusive and Partial Enteral Nutrition: A Pilot Study in Adults

Author(s) -

Catherine L. Wall,

Richard B. Gearry,

Andrew S. Day

Publication year - 2017

Publication title -

inflammatory intestinal diseases

Language(s) - English

Resource type - Journals

eISSN - 2296-9403

pISSN - 2296-9365

DOI - 10.1159/000489630

Subject(s) - medicine , calprotectin , crohn's disease , parenteral nutrition , faecal calprotectin , inflammatory bowel disease , prospective cohort study , gastroenterology , c reactive protein , disease , ulcerative colitis , inflammation

Enteral nutrition (EN) is not commonly used for the treatment of adults with active Crohn's disease (CD), despite patient interest in nutrition-based alternatives to corticosteroids and evidence of efficacy in paediatric CD. The aim of this study was to assess the impact of 2 different EN regimens on disease symptoms, nutrition and inflammatory markers in young adults with active CD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research